Fulcrum Therapeutics Inc (NASDAQ: FULC) kicked off on Monday, up 3.54% from the previous trading day, before settling in for the closing price of $11.58. Over the past 52 weeks, FULC has traded in a range of $2.32-$15.74.
During the last 5-year period, the sales growth of Healthcare Sector giant was 54.59%. While this was happening, its average annual earnings per share was recorded -629.38%. With a float of $59.86 million, this company’s outstanding shares have now reached $65.97 million.
Fulcrum Therapeutics Inc (FULC) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Fulcrum Therapeutics Inc is 9.27%, while institutional ownership is 67.44%. The most recent insider transaction that took place on Dec 15 ’25, was worth 44,600. In this transaction Chief Legal Officer of this company sold 3,452 shares at a rate of $12.92, taking the stock ownership to the 10,252 shares. Before that another transaction happened on Dec 15 ’25, when Company’s Officer proposed sale 3,452 for $13.00, making the entire transaction worth $44,876.
Fulcrum Therapeutics Inc (FULC) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.31 earnings per share (EPS), lower than consensus estimate (set at -0.29) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.29 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -629.38% per share during the next fiscal year.
Fulcrum Therapeutics Inc (NASDAQ: FULC) Trading Performance Indicators
Take a look at Fulcrum Therapeutics Inc’s (FULC) current performance indicators. Last quarter, stock had a quick ratio of 17.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.18, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -1.19 in one year’s time.
Technical Analysis of Fulcrum Therapeutics Inc (FULC)
Looking closely at Fulcrum Therapeutics Inc (NASDAQ: FULC), its last 5-days average volume was 0.73 million, which is a drop from its year-to-date volume of 0.75 million. As of the previous 9 days, the stock’s Stochastic %D was 19.51%.
During the past 100 days, Fulcrum Therapeutics Inc’s (FULC) raw stochastic average was set at 60.38%, which indicates a significant increase from 13.28% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.95 in the past 14 days, which was higher than the 0.67 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.34, while its 200-day Moving Average is $7.30. However, in the short run, Fulcrum Therapeutics Inc’s stock first resistance to watch stands at $12.19. Second resistance stands at $12.38. The third major resistance level sits at $12.74. If the price goes on to break the first support level at $11.64, it is likely to go to the next support level at $11.28. Should the price break the second support level, the third support level stands at $11.09.
Fulcrum Therapeutics Inc (NASDAQ: FULC) Key Stats
The company with the Market Capitalisation of 790.98 million has total of 54,118K Shares Outstanding. Its annual sales at the moment are 80,000 K in contrast with the sum of -9,730 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -19,600 K.
